A federal judge has issued a ruling to stay the FDA's approval of the abortion drug mifepristone, in response to a lawsuit brought by anti-abortion groups in Texas. The ruling invalidates the FDA's 23-year-old approval of the drug, and the groups have urged the 5th U.S. Circuit Court of Appeals to let the ruling stand. The case is likely to be taken to the Supreme Court, and the outcome could have a significant impact on access to the medication.
Posts tagged as “Matthew Kacsmaryk”
A U.S. District Court judge in Texas ruled that the FDA's approval of mifepristone was illegal, sparking a debate over the future of abortion access in the United States. Democrats have called on the Biden administration to ignore the ruling, but the administration has yet to announce what action it will take. The FDA is expected to make a statement soon.
The Department of Justice has filed a request in a federal appeals court to block a ruling from a Trump-appointed judge that would have endangered access to the abortion pill mifepristone. The Biden administration is arguing that the ruling is "extraordinary and unprecedented" and should be stayed pending appeal. The FDA approved mifepristone in 2000 and it has since become one of the most commonly used abortion pills, used in combination with another drug to terminate a pregnancy.

Biden Administration Prepares to Defend FDA Approval of Abortion Drug Despite Federal Judge’s Ruling
The Biden administration has responded to a recent ruling from a federal judge in Texas that suspended the approval of a medication drug used for abortion. Rep. Nancy Mace, a Republican congresswoman, has urged the FDA to ignore the ruling, while Jones, spokeswoman for the Department of Health and Human Services, stated that the agency is prepared to defend the approval through the legal process. The FDA has not yet commented on the ruling or the administration's response, leaving the future of the drug uncertain.
Xavier Becerra, President Joe Biden's health secretary, has spoken out against a court ruling that threatens the availability of a main drug used in medication abortion. The ruling, made by Donald Trump-appointee Matthew Kacsmaryk in Texas, has been met with criticism from reproductive rights advocates. The Biden administration has committed to protecting women's reproductive rights and will do whatever is necessary to ensure that women have access to the medication they need.
A U.S. District Judge appointed by former President Donald Trump has suspended the FDA's approval of abortion pills, sparking outrage among Congressional Democrats. Chuck Schumer has urged Republicans to speak out against the ruling, while President Joe Biden has said his administration will file an appeal. Republicans in Congress have yet to respond to the ruling.
A federal judge has issued an injunction suspending the Food and Drug Administration's (FDA) approval of the abortion pill mifepristone, potentially impacting access to medication abortions nationwide. U.S. District Judge Matthew Kacsmaryk ruled that the FDA's two-decade-old approval of the drug violated a federal rule and was unlawful. The government has a week to appeal the decision, which could have far-reaching implications for abortion access in the United States.
A federal judge in Texas heard arguments Wednesday in a case that could potentially threaten the most common form of abortion in the United States. U.S. District Judge Matthew Kacsmaryk heard arguments from the Alliance Defending Freedom lawyers to revoke or suspend the approval of the abortion medication mifepristone, which has been used by millions of American women for over two decades. Judge Kacsmaryk did not issue a ruling Wednesday, but the outcome of the case could have far-reaching implications for women’s reproductive rights in the United States.






